371
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone

, , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tewodros Shibabaw, Banchamlak Teferi, Meseret Derbew Molla & Birhanu Ayelign. (2020) Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer. Breast Cancer: Targets and Therapy 12, pages 165-180.
Read now

Articles from other publishers (19)

V. N. Blindar, G. N. Zubrikhina, T. V. Davydova & M. M. Dobrovolskaya. (2023) Features of regulation of hepcidin and ferroportin in cancer patients (literary review). Russian Journal of Biotherapy 22:3, pages 10-18.
Crossref
Malgorzata Osmola, Beata Gierej, Katarzyna Mleczko-Sanecka, Aneta Jończy, Olga Ciepiela, Leszek Kraj, Bogna Ziarkiewicz-Wróblewska & Grzegorz Władysław Basak. (2023) Anemia, Iron Deficiency, and Iron Regulators in Pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis. Current Oncology 30:8, pages 7722-7739.
Crossref
V. N. Blindar, G. N. Zubrikhina, T. V. Davydova, M. M. Dobrovolskaya, M. N. Khagazheeva, A. V. Snegovoy, D. A. Ryabchikov, N. V. Lyubimova, N. E. Kushlinsky & I. B. Kononenko. (2022) Peculiarities of iron metabolism in patients with breast cancer before adjuvant chemotherapy. Russian Journal of Biotherapy 21:1, pages 33-41.
Crossref
Myriam Y. Hsu, Erica Mina, Antonella Roetto & Paolo E. Porporato. (2020) Iron: An Essential Element of Cancer Metabolism. Cells 9:12, pages 2591.
Crossref
Katarzyna J. Jerzak, Ana E. Lohmann, Marguerite Ennis, Elizabeta Nemeth, Tomas Ganz & Pamela J. Goodwin. (2020) Prognostic associations of plasma hepcidin in women with early breast cancer. Breast Cancer Research and Treatment 184:3, pages 927-935.
Crossref
Pierre Lelièvre, Lucie Sancey, Jean-Luc Coll, Aurélien Deniaud & Benoit Busser. (2020) Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy. Cancers 12:12, pages 3524.
Crossref
Takeshi Aiyama, Tatsuya Orimo, Hideki Yokoo, Takanori Ohata, Kanako C. Hatanaka, Yutaka Hatanaka, Moto Fukai, Toshiya Kamiyama & Akinobu Taketomi. (2020) Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis. PLOS ONE 15:9, pages e0239462.
Crossref
C. Callens. (2019) Fer et cancers : l’exemple du cancer du sein. Bulletin de l'Académie Nationale de Médecine 203:6, pages 424-431.
Crossref
Masaki Hara, Yuya Nakamura, Hiroki Suzuki, Rin Asao, Masayuki Nakamura, Kazumasa Nishida, Sachiyo Kenmotsu, Masahiro Inagaki, Mayumi Tsuji, Yuji Kiuchi, Isao Ohsawa, Yoshikazu Goto & Hiromichi Gotoh. (2019) Hepcidin‐25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate. Nephrology 24:8, pages 819-826.
Crossref
Fady M. El Gendy, Mahmoud A. EL‐Hawy, Amira M. F. Shehata & Hanaa E. Osheba. (2018) Erythroferrone and iron status parameters levels in pediatric patients with iron deficiency anemia. European Journal of Haematology 100:4, pages 356-360.
Crossref
Driton Vela & Zana Vela-Gaxha. (2018) Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. Experimental & Molecular Medicine 50:2, pages e436-e436.
Crossref
Erdong Zuo, Ye Lu, Min Yan, Xiangtao Pan & Xu Cheng. (2017) Increased expression of hepcidin and associated upregulation of JAK/STAT3 signaling in human gastric cancer. Oncology Letters.
Crossref
Nilgün Gedik, Eva Kottenberg, Matthias Thielmann, Ulrich H. Frey, Heinz Jakob, Jürgen Peters, Gerd Heusch & Petra Kleinbongard. (2017) Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization. Scientific Reports 7:1.
Crossref
Sara Pizzamiglio, Maida De Bortoli, Elena Taverna, Michele Signore, Silvia Veneroni, William Cho, Rosaria Orlandi, Paolo Verderio & Italia Bongarzone. (2017) Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors. International Journal of Molecular Sciences 18:2, pages 410.
Crossref
D L Indrakanti, A Alvarado, X Zhang, D J Birmingham, A Hinton & B H Rovin. (2016) The interleukin-6-hepcidin-hemoglobin circuit in systemic lupus erythematosus flares. Lupus 26:2, pages 200-203.
Crossref
Chih-Wei Chang, Yi-Ming Chen, Yi-Ju Hsu, Chi-Chang Huang, Yu-Tse Wu & Mei-Chich Hsu. (2016) Protective effects of the roots of Angelica sinensis on strenuous exercise-induced sports anemia in rats. Journal of Ethnopharmacology 193, pages 169-178.
Crossref
Roberta Russo, Immacolata AndolfoFrancesco MannaGianluca De RosaLuigia De FalcoAntonella GambaleMariasole Bruno, Alessandro Mattè, Paolo Ricchi, Domenico Girelli, Lucia De Franceschi & Achille Iolascon. (2016) Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II. Blood 128:14, pages 1899-1902.
Crossref
Athina Drakou, Alexandra Margeli, Stamatia Theodorakopoulou, Ioannis Agrogiannis, Christos Poziopoulos, Ioannis Papassotiriou & Demetrios V. Vlahakos. (2016) Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose. Blood Cells, Molecules, and Diseases 59, pages 100-105.
Crossref
Hirokazu Honda, Yasuna Kobayashi, Shoko Onuma, Keigo Shibagaki, Toshitaka Yuza, Keiichi Hirao, Toshinori Yamamoto, Naohisa Tomosugi & Takanori Shibata. (2016) Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis. PLOS ONE 11:3, pages e0151601.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.